124 related articles for article (PubMed ID: 8266231)
1. Seasonal changes in serum and erythrocyte potassium among renal stone formers from northeastern Thailand.
Sriboonlue P; Tungsanga K; Tosukhowong P; Sitprija V
Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):287-92. PubMed ID: 8266231
[TBL] [Abstract][Full Text] [Related]
2. Some aspects of citrate metabolism in renal-stone patients from northeastern Thailand.
Sriboonlue P; Prasongwatana V; Borvornpadoongkitti S; Suwantrai S
J Med Assoc Thai; 1996 Nov; 79(11):737-43. PubMed ID: 8997014
[TBL] [Abstract][Full Text] [Related]
3. Blood and urinary aggregator and inhibitor composition in controls and renal-stone patients from northeastern Thailand.
Sriboonlue P; Prasongwattana V; Tungsanga K; Tosukhowong P; Phantumvanit P; Bejraputra O; Sitprija V
Nephron; 1991; 59(4):591-6. PubMed ID: 1766498
[TBL] [Abstract][Full Text] [Related]
4. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
[TBL] [Abstract][Full Text] [Related]
5. Urinary acidification in renal stone patients from northeastern Thailand.
Tungsanga K; Sriboonlue P; Borwornpadungkitti S; Tosukhowong P; Sitprija V
J Urol; 1992 Feb; 147(2):325-8. PubMed ID: 1732585
[TBL] [Abstract][Full Text] [Related]
6. Nutritional potassium status of healthy adult males residing in the rural northeast Thailand.
Sriboonlue P; Prasongwatana V; Suwantrai S; Bovornpadungkitti S; Tungsanga K; Tosukhowong P
J Med Assoc Thai; 1998 Mar; 81(3):223-32. PubMed ID: 9623015
[TBL] [Abstract][Full Text] [Related]
7. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
8. [Citrate and kidney stones].
Osther PJ
Ugeskr Laeger; 1993 Nov; 155(47):3835-9. PubMed ID: 8256384
[TBL] [Abstract][Full Text] [Related]
9. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
10. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and low urinary citrate excretion in calcium stone formers.
Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
[TBL] [Abstract][Full Text] [Related]
12. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
13. Citrate excretion in spinal cord patients.
Burr RG; Nuseibeh I
Paraplegia; 1990 Oct; 28(8):496-504. PubMed ID: 2263406
[TBL] [Abstract][Full Text] [Related]
14. [Renal tubular function in children with hypercalciuria].
Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
[TBL] [Abstract][Full Text] [Related]
15. Urinary citrate excretion in patients with renal stone: roles of leucocyte ATP citrate lyase activity and potassium salts therapy.
Tosukhowong P; Borvonpadungkitti S; Prasongwatana V; Tungsanga K; Jutuporn S; Dissayabutr T; Reungjui S; Sriboonlue P
Clin Chim Acta; 2002 Nov; 325(1-2):71-8. PubMed ID: 12367768
[TBL] [Abstract][Full Text] [Related]
16. In vivo 31P-MRS assessment of muscle-pH, cytolsolic-[Mg2+] and phosphorylation potential after supplementing hypokaliuric renal stone patients with potassium and magnesium salts.
Mairiang E; Hanpanich P; Sriboonlue P
Magn Reson Imaging; 2004 Jun; 22(5):715-9. PubMed ID: 15172066
[TBL] [Abstract][Full Text] [Related]
17. Seasonal variations in urinary risk factors among patients with nephrolithiasis.
Stuart RO 2nd ; Hill K; Poindexter J; Pak CY
J Lithotr Stone Dis; 1991 Jan; 3(1):18-27. PubMed ID: 11536932
[TBL] [Abstract][Full Text] [Related]
18. [Sodium excretion in children with lithogenic disorders].
Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
[TBL] [Abstract][Full Text] [Related]
19. Urinary citrate in kidney stone disease.
Usui Y; Matsuzaki S; Matsushita K; Shima M
Tokai J Exp Clin Med; 2003 Jul; 28(2):65-70. PubMed ID: 14714831
[TBL] [Abstract][Full Text] [Related]
20. Effects of potassium-magnesium citrate supplementation on cytosolic ATP citrate lyase and mitochondrial aconitase activity in leukocytes: a window on renal citrate metabolism.
Tosukhowong P; Tungsanga K; Phongudom S; Sriboonlue P
Int J Urol; 2005 Feb; 12(2):140-4. PubMed ID: 15733107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
